Zebra Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Zebra Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,881	Closed	-$469K	–	171
2020 Q3	$469K	Buy	+8,881	New	+$548K	0.72%	48
2020 Q1	–	Sell	-3,639	Closed	-$207K	–	305
2019 Q4	$207K	Buy	+3,639	New	+$193K	0.18%	232
2018 Q4	–	Sell	-3,619	Closed	-$212K	–	449
2018 Q3	$212K	Buy	+3,619	New	+$185K	0.1%	369

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Zebra Capital Management's BSTC Position: Q4 2020 in Review

Zebra Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 8,881 shares — an estimated $469K sold.

Zebra Capital Management first reported a position in BSTC in Q3 2018 and held it in 3 quarters. The position peaked at $469K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Zebra Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Zebra Capital Management sold 8,881 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $469K.
Zebra Capital Management first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 3 quarters.
Zebra Capital Management's BioSpecifics Technologies Corp. position peaked at $469K in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Zebra Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.